GB 12 Chewable Tablet contains Methylcobalamin 1500 mcg, an active form of vitamin B12 essential for neurological function, hematopoiesis, and DNA synthesis. This formulation is indicated for the prevention and treatment of vitamin B12 deficiency, which may present as megaloblastic anemia, peripheral neuropathy, or cognitive disturbances. Methylcobalamin plays a critical role in the maintenance of myelin sheath integrity and supports nerve regeneration, making GB 12 particularly beneficial in managing neuropathic conditions such as diabetic neuropathy, alcoholic neuropathy, and certain neurodegenerative disorders. The chewable tablet form enhances patient compliance, especially in individuals with swallowing difficulties or pediatric patients. Upon administration, Methylcobalamin is readily absorbed and utilized in cellular metabolic processes, contributing to improved neurological function and hematological parameters. GB 12 is generally well tolerated with a low incidence of adverse effects; however, hypersensitivity reactions may occur rarely. It is recommended to use this product under medical supervision, particularly in patients with underlying conditions such as Leber’s disease or those receiving concomitant folate therapy. Regular monitoring of vitamin B12 levels and clinical response is advised to optimize therapeutic outcomes. GB 12 Chewable Tablet offers an effective and convenient option for addressing vitamin B12 deficiency and associated neurological impairments.